Claudia Venturi

624 total citations
23 papers, 234 citations indexed

About

Claudia Venturi is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Claudia Venturi has authored 23 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 15 papers in Genetics and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Claudia Venturi's work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). Claudia Venturi is often cited by papers focused on Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). Claudia Venturi collaborates with scholars based in Italy, Czechia and United States. Claudia Venturi's co-authors include Cristina Papayannidis, Giovanni Martinelli, Ilaria Iacobucci, Michèle Cavo, Stefania Paolini, Domenico Russo, Simona Soverini, Paola Bresciani, Mario Luppi and Emanuela Ottaviani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Claudia Venturi

21 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Venturi Italy	8	175	92	89	61	56	23	234
Jana Linhartová Czechia	7	191 1.1×	79 0.9×	120 1.3×	46 0.8×	45 0.8×	13	242
Maria Chiara Abbenante Italy	7	83 0.5×	66 0.7×	45 0.5×	80 1.3×	45 0.8×	27	173
Fabian Lang Germany	8	227 1.3×	33 0.4×	164 1.8×	67 1.1×	53 0.9×	39	285
Bartlomiej Getta United States	6	184 1.1×	54 0.6×	117 1.3×	64 1.0×	31 0.6×	19	236
Soo-Young Choi South Korea	8	147 0.8×	20 0.2×	117 1.3×	62 1.0×	24 0.4×	20	223
Simone Claudiani United Kingdom	8	165 0.9×	29 0.3×	136 1.5×	19 0.3×	45 0.8×	31	209
Uwe Schwindel Germany	4	279 1.6×	38 0.4×	238 2.7×	48 0.8×	30 0.5×	4	345
Nataliia Glushko Ukraine	2	275 1.6×	34 0.4×	217 2.4×	42 0.7×	77 1.4×	2	327
K R Reynolds United States	5	104 0.6×	22 0.2×	72 0.8×	66 1.1×	11 0.2×	10	190
Sherry Pierce United States	4	262 1.5×	222 2.4×	58 0.7×	104 1.7×	72 1.3×	5	342

Countries citing papers authored by Claudia Venturi

Since Specialization

Citations

This map shows the geographic impact of Claudia Venturi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Venturi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Venturi more than expected).

Fields of papers citing papers by Claudia Venturi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Venturi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Venturi. The network helps show where Claudia Venturi may publish in the future.

Co-authorship network of co-authors of Claudia Venturi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Venturi. A scholar is included among the top collaborators of Claudia Venturi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Venturi. Claudia Venturi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ottaviani, Emanuela, Manuela Mancini, Claudia Venturi, et al.. (2023). Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights. Cells. 12(13). 1703–1703. 7 indexed citations

Soverini, Simona, Maurizio Martelli, Fausto Castagnetti, et al.. (2022). Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia. Leukemia. 36(9). 2250–2260. 14 indexed citations

Lee, Sharon Wei Ling, et al.. (2021). A Human Neurovascular Unit On-a-Chip. Methods in molecular biology. 2373. 107–119. 3 indexed citations

Bruno, Samantha, Valentina Robustelli, Claudia Venturi, et al.. (2021). Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 728613–728613. 5 indexed citations

Bochicchio, Maria Teresa, Jessica Petiti, Paola Berchialla, et al.. (2021). Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?. Cancers. 13(21). 5470–5470. 9 indexed citations

Fava, Carmen, Paola Berchialla, Jessica Petiti, et al.. (2019). A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia. Blood. 134(Supplement_1). 2092–2092. 3 indexed citations

Daraio, Filomena, Emilia Giugliano, Carmen Fava, et al.. (2017). An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease. Blood. 130. 4176–4176. 1 indexed citations

Benedittis, Caterina De, Cristina Papayannidis, Claudia Venturi, et al.. (2017). The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report. BMC Cancer. 17(1). 523–523. 1 indexed citations

Trino, Stefania, Ilaria Iacobucci, Ilaria Laurenzana, et al.. (2016). Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients. Oncotarget. 7(11). 12951–12961. 31 indexed citations

10.

Trino, Stefania, Luciana De Luca, Vittorio Simeon, et al.. (2015). Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia. Tumor Biology. 37(1). 217–225. 2 indexed citations

11.

Zuffa, Elisa, Eugenia Franchini, Cristina Papayannidis, et al.. (2015). Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients. Oncotarget. 6(31). 31284–31294. 17 indexed citations

12.

Iacobucci, Ilaria, Annalisa Lonetti, Claudia Venturi, et al.. (2014). Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. Leukemia Research. 38(5). 581–585. 18 indexed citations

13.

Ferrari, Anna, Cristina Papayannidis, Carmen Baldazzi, et al.. (2014). Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome. Blood. 124(21). 2379–2379. 7 indexed citations

14.

Bochicchio, Maria Teresa, Barbara Izzo, Enrico Gottardi, et al.. (2014). Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients. Blood. 124(21). 1809–1809. 3 indexed citations

15.

Sartor, Chiara, Cristina Papayannidis, Maria Chiara Abbenante, et al.. (2013). Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome. SHILAP Revista de lepidopterología. 5(2). e7–e7. 5 indexed citations

16.

Iacobucci, Ilaria, Andrea Ghelli Luserna di Rorà, Maria Vittoria Verga Falzacappa, et al.. (2013). Abstract 705: Inhibition of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) is a novel therapeutic strategy in B- and T-Acute Lymphoblastic Leukemia (ALL).. Cancer Research. 73(8_Supplement). 705–705. 1 indexed citations

17.

Soverini, Simona, Caterina De Benedittis, Cristina Papayannidis, et al.. (2013). Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement. Cancer. 120(7). 1002–1009. 99 indexed citations

18.

Soverini, Simona, Caterina De Benedittis, Kateřina Machová Poláková, et al.. (2013). Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy. Blood. 122(21). 380–380. 2 indexed citations

19.

Iacobucci, Ilaria, Andrea Ghelli Luserna di Rorà, Maria Vittoria Verga Falzacappa, et al.. (2012). In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL). Blood. 120(21). 1496–1496. 3 indexed citations

20.

Iacobucci, Ilaria, Anna Ferrari, Cristina Papayannidis, et al.. (2012). Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia.. Blood. 120(21). 2522–2522. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact